Kinarus Therapeutics Holding AG (XSWX:KNRS) LT-Debt-to-Total-Asset : 3.15 (As of Dec. 2021)

View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Kinarus Therapeutics Holding AG's long-term debt to total assests ratio for the quarter that ended in Dec. 2021 was 3.15.

Kinarus Therapeutics Holding AG's long-term debt to total assets ratio increased from Dec. 2020 (2.21) to Dec. 2021 (3.15). It may suggest that Kinarus Therapeutics Holding AG is progressively becoming more dependent on debt to grow their business.

Kinarus Therapeutics Holding AG LT-Debt-to-Total-Asset Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG LT-Debt-to-Total-Asset Chart

Kinarus Therapeutics Holding AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.07

0.08

0.45

2.21

3.15

Kinarus Therapeutics Holding AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.45	0.37	2.21	1.30	3.15

Kinarus Therapeutics Holding AG LT-Debt-to-Total-Asset Calculation

Kinarus Therapeutics Holding AG's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )	/	Total Assets (A: Dec. 2021 )
	=	0.429	/	0.136
	=

Kinarus Therapeutics Holding AG's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (Q: Dec. 2021 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2021 )	/	Total Assets (Q: Dec. 2021 )
	=	0.429	/	0.136
	=

Kinarus Therapeutics Holding AG (XSWX:KNRS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Kinarus Therapeutics Holding AG LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

3, Avenue de Florimont, Lausanne, CHE, CH-1006

Website

https://www.perfect.aero

Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines